-
Medical journals
- Career
Athero Review - Issue 3/2019
Editorial
123
Guidelines
126A statement of the Committee of the Czech Society for Atherosclerosis on the 2019 ESC/EAS Recommendations for the diagnosis and treatment of dyslipidemiaMichal Vrablík, Jan Piťha, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Zuzana Urbanová Za Výbor Čsat
138145The effect of statins on podocytes in nephrotic syndromePeter Habara, Marie Claire Šmůlová, Pavla Fialová, Jan Krtil, Karolína Krátká, Ivan Rychlík
153Dyslipidemia in patients with chronic kidney diseaseMagdaléna Dušejovská, Marek Vecka, Ivan Rychlík, Aleš Žák
159Apolipoprotein L1 – ethnically specific determinant of renal and heart failureJaroslav A. Hubáček
144
clinical studies
162Observational study of dyslipidemia management in the Czech RepublicLukáš Zlatohlávek, Michaela Šnejdrlová, Ian Bridges, Romana Šindelářová
171Lysosomal acid lipase deficiency: one of the possible causes of dyslipidemia and hepatopathyEva Tůmová, Michal Vrablík
176Vitamin D and coronary artery risk detected by computed tomographyDominik Pella, Claudia Gibarti, Zuzana Pella, Jozef Gonsorčík
181Ten ways of using ezetimibe, or a brief guide to its use todayMartin Šatný, Michal Vrablík
185
From International Literature
189
Annoucements
191193Šobrův den 2019: Lipidologie opět na výsluníKristýna Čillíková
Athero Review
2019 Issue 3
Most read in this issue- Ten ways of using ezetimibe, or a brief guide to its use today
- A statement of the Committee of the Czech Society for Atherosclerosis on the 2019 ESC/EAS Recommendations for the diagnosis and treatment of dyslipidemia
- Specificities of the treatment for vascular system diseases in patients with a chronic renal disease
- Dyslipidemia in patients with chronic kidney disease
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career